BRONTUSS DX- dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride liquid 
Portal Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Brontuss DX

Drug Facts

Active ingredients                             Purpose
(in each 5 mL teaspoonful)
Dextromethorphan Hydrobromide 20 mg...... Antitussive
Guaifenesin 200 mg................................ Expectorant
Phenylephrine Hydrochloride 10 mg..........Decongestant

Uses

temporarily relieves these symptoms, due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

Warnings

Do not exceed recommended dosage.

Do not use this product

  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

Ask a doctor before use if you have

  • a cough that lasts or is chronic such as occurs with smoking, asthma or emphysema
  • a cough that occurs with too much phlegm (mucus)
  • heart disease
  • high blood pressure
  • thyroid disease
  • diabetes
  • trouble urinating due to an enlarged prostate gland

Stop use and ask a doctor if

  • nervousness, dizziness, or sleeplessness occur
  • cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache. These could be signs of a serious condition.
  • new symptoms occur

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.

Directions

Do not exceed recommended dosage.
Adults and Children 12 years of age and older:             
2 teaspoonfuls (10mL) every 6 hours, not to exceed 4 doses in a 24 hour period.
Children 6 to under 12 years of age:
1 teaspoonful (5 mL) every 6 hours, not to exceed 4 doses in a 24 hour period.
Children under 6 years of age:
Not recommended for use.

Other information

Store at 59o-86oF (15o-30oC)

Inactive ingredients

cherry flavor, citric acid, maltitol, propylene glycol, purified water, sodium citrate, sodium saccharin, and sorbitol.

Questions? Comments?

Serious side effects associated with this product may be reported to this number.
Call (787)832-6645
Operation Hours: Monday - Friday, 8 A.M. to 4 P.M. Atlantic Standard Time (AST)
portalpharmaceutical@gmail.com

Manufactured for:

Portal Pharmaceutical
Mayaguez, PR 00680

Rev. 10/09

PRODUCT PACKAGING:

The packaging below represents the labeling currently used:

Principal Display Panel and Side Panel for 118mL Label:

NDC 49963-913-04

Brontuss
DX

Antitussive / Expectorant
Decongestant

Each teaspoonful (5 mL) for oral administration contains:
Dextromethorphan HBr.............. 20 mg
Guaifenesin.............................200 mg
Phenylephrine HCl.................... 10 mg


Dye Free - Sugar Free

Alcohol Free - Gluten Free

4 oz. (118 mL)

Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.

Supplied in a tight, light-resistant container with a child-resistant cap.

Manufactured for:
Portal Pharmaceutical
Mayaguez, PR 00680

Rev. 10/09

Principal Display Panel and Side Panel for 15 mL Label:

NDC 49963-913-15

Brontuss
DX

Antitussive / Expectorant
Decongestant

Each teaspoonful (5 mL) for oral administration contains:
Dextromethorphan HBr.......... 20 mg
Guaifenesin........................ 200 mg
Phenylephrine HCl................ 10 mg

Dye Free / Sugar Free
Alcohol Free / Gluten Free

15 mL (1/2 fl oz)

Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.
Supplied in a tight, light-resistant container with a child-resistant cap.

Professional Sample:

Not For Sale

Manufactured for:
Portal Pharmaceutical
Mayaguez, PR 00680

Rev. 10/09

Brontuss DX Packaging

Brontuss DX Packaging

Brontuss DX Packaging

Brontuss DX Packaging

BRONTUSS  DX
dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49963-913
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Dextromethorphan Hydrobromide (UNII: 9D2RTI9KYH) (Dextromethorphan - UNII:7355X3ROTS) Dextromethorphan Hydrobromide20 mg  in 5 mL
Guaifenesin (UNII: 495W7451VQ) (Guaifenesin - UNII:495W7451VQ) Guaifenesin200 mg  in 5 mL
Phenylephrine Hydrochloride (UNII: 04JA59TNSJ) (Phenylephrine - UNII:1WS297W6MV) Phenylephrine Hydrochloride10 mg  in 5 mL
Product Characteristics
Color    Score    
ShapeSize
FlavorCHERRYImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49963-913-04118 mL in 1 BOTTLE
2NDC:49963-913-1515 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34111/24/2009
Labeler - Portal Inc. (831005199)

Revised: 12/2009
Document Id: 5012801b-7bba-48d0-8636-68300642c6bd
Set id: c83c41c1-e66f-4aea-82ad-2028dbf50f95
Version: 2
Effective Time: 20091217
 
Portal Inc.